You are viewing: Singapore Latent TB Testing Market analysis
Part of: Latent TB Testing Market (Global)

The Singapore Latent TB Testing Market was valued at $3.04 Million in 2024 and projected to reach to $4.09 Million by 2029, representing a compound annual growth rate of 6.1%. Singapore's latent TB testing market is poised for sustained growth through 2029, driven by the nation's commitment to TB elimination and strengthened disease surveillance infrastructure.

Singapore Latent TB Testing Market (2024-2029) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

Singapore Latent TB Testing Market Trends and Insights

  • Singapore's advanced healthcare infrastructure and strong disease surveillance systems position the nation as a leader in TB diagnostics within Asia Pacific.
  • The market growth is driven by Singapore's commitment to TB elimination, increased screening programs in high-risk populations, and adoption of innovative testing technologies. The latent TB testing sector in Singapore benefits from robust public health initiatives and private healthcare investment.
  • Singapore's strategic location as a regional hub attracts multinational diagnostic companies, enhancing market competition and innovation.
  • Between 2024 and 2029, Singapore is expected to see increased demand for rapid, accurate testing methods as healthcare providers prioritize early detection and treatment of latent TB infection to prevent progression to active disease..

Key Market Statistics

  • CAGR (2024-2029) 6.1% CAGR
  • Market Size, 2024 ~USD 3.04 Million
  • Forecast, 2029 ~USD 4.09 Million
  • Country Singapore

Singapore Latent TB Testing Market Overview

Market Valuation & Growth :

Singapore's latent TB testing market is valued at $3.04 million in 2024, with a projected CAGR of 6.1% through 2029, reaching $4.09 million. This outpaces the global CAGR of 5.8%, reflecting strong regional demand.

Advanced Healthcare Infrastructure :

Singapore's world-class healthcare system and robust disease surveillance mechanisms position it as a regional leader in TB diagnostics. The nation's investment in diagnostic technologies and public health initiatives drives market expansion.

Strategic Regional Hub :

As a major healthcare and medical tourism destination in Asia Pacific, Singapore serves as a benchmark for TB testing standards and innovation, influencing diagnostic adoption across Southeast Asia.

Government TB Control Programs :

Singapore's comprehensive TB elimination strategy and mandatory screening protocols in healthcare facilities and high-risk populations support consistent demand for latent TB testing solutions.

Singapore Latent TB Testing Market Dynamics

  • The government's proactive screening initiatives in healthcare settings and migrant worker populations will continue to fuel demand for advanced diagnostic solutions.
  • Singapore's position as a regional medical hub and its adoption of cutting-edge testing technologies position the market favorably for expansion.
  • Increasing awareness among healthcare providers and patients, combined with rising healthcare expenditure, will support market penetration of newer latent TB testing modalities..

Related Ecosystem

Medical Devices

Top Technologies
  • Polymerase Chain Reaction (PCR)
  • Magnetic Resonance Imaging (MRI)
  • Disposable Autoinjectors
  • Pulse Oximeters
  • Blood Pressure Monitors
Top Companies
  • Medtronic plc
  • Abbott Laboratories
  • Stryker Corporation
  • Becton, Dickinson and Company
  • CONMED Corporation

    Key Takeaways

    • Singapore's latent TB testing market is valued at $3.04 million in 2024 and is forecast to reach $4.09 million by 2029.
    • Singapore demonstrates a 6.1% CAGR, reflecting strong healthcare investment and TB elimination initiatives.
    • Singapore's advanced diagnostic infrastructure and regional hub status drive adoption of innovative testing technologies.
    • Singapore's public health commitment to TB control supports sustained market expansion through 2029.

    Latent TB Testing Market Report Scope

    Report Metric Details
    Base Year 2024
    Fastest Growing Segment HOUSEHOLD CONTACTS WITH PULMONARY TB (Application)
    Forecast Period 2024-2029
    Growth Rate CAGR of 5.8% from 2024 to 2029
    Largest Segment IGRA (Test Type)
    Market Size Base Year (Billions) ~USD 0.58 (2024)
    Revenue Forecast (Billions) ~USD 0.77 (2029)
    Segments Covered Test Type, Application, End User

    Singapore Latent TB Testing Market Report Segmentation

    3 segment dimensions are covered across the global market.

    By Test Type

    • Igra
    • Tst

    By Application

    • Household Contacts With Pulmonary Tb
    • Other Applications
    • People Living With Hiv

    By End User

    • Academic & Research Institutes
    • Diagnostic Laboratories
    • Hospitals & Clinics
    • Other End Users

    SINGAPORE: LATENT TB TESTING MARKET, BY END USER, 2022–2029

    Segment20222023202420252026202720282029CAGR (%)
    ACADEMIC & RESEARCH INSTITUTES0.20.230.230.240.250.260.270.294.3
    DIAGNOSTIC LABORATORIES1.792.12.182.292.422.582.772.996.5
    HOSPITALS & CLINICS0.580.670.680.710.740.770.820.874.8
    OTHER END USERS0.110.130.130.130.140.140.150.163.7
    TOTAL2.683.133.233.373.543.764.014.35.9

    Target Audience

    • Diagnostic Device Manufacturers : Need Singapore-specific market data to assess commercial viability, identify healthcare facility adoption rates, and develop localized product strategies for latent TB testing solutions in this premium market.
    • Healthcare System Administrators : Require market insights to optimize TB screening program budgets, evaluate diagnostic technology investments, and benchmark Singapore's testing protocols against regional standards and best practices.
    • Investment & Private Equity Firms : Seek detailed Singapore market forecasts and growth drivers to evaluate investment opportunities in diagnostic companies, healthcare providers, and TB control initiatives with regional expansion potential.
    • Public Health & Government Agencies : Need market intelligence to inform TB elimination strategy refinement, allocate resources for screening programs, and assess the effectiveness of latent TB testing initiatives in Singapore.
    • Regional Healthcare Consultants : Require Singapore market data to advise clients on diagnostic adoption trends, competitive landscape, and growth opportunities for TB testing services across Asia Pacific operations.

    Reasons to Buy this Report

    • Precise Market Sizing for Singapore : Obtain accurate 2024 baseline ($3.04M) and 2029 forecast ($4.09M) data specific to Singapore's latent TB testing market, enabling precise investment and expansion planning in this high-growth regional market.
    • Regional Benchmark Intelligence : Understand Singapore's market dynamics relative to global trends (5.8% vs 6.1% CAGR), providing competitive insights for positioning diagnostic solutions in Asia Pacific's most advanced healthcare economy.
    • Government Policy & Screening Insights : Gain detailed understanding of Singapore's TB elimination strategy, mandatory screening protocols, and migrant worker testing programs that drive consistent market demand and regulatory requirements.
    • Healthcare Provider Strategy : Identify opportunities within Singapore's advanced healthcare infrastructure, including public hospitals, private clinics, and occupational health services implementing latent TB testing protocols.
    • Market Entry & Expansion Planning : Leverage Singapore-specific market data to develop targeted go-to-market strategies, partnership opportunities, and product positioning for regional expansion across Southeast Asia.

    Frequently asked questions

    What is the current size of Singapore's latent TB testing market?

    Singapore's latent TB testing market was valued at $3.04 million in 2024 and is expected to grow to $4.09 million by 2029.

    What is the projected growth rate for latent TB testing in Singapore?

    Singapore's latent TB testing market is projected to grow at a compound annual growth rate (CAGR) of 6.1% from 2024 to 2029.

    What factors are driving growth in Singapore's latent TB testing market?

    Growth in Singapore's latent TB testing market is driven by advanced healthcare infrastructure, strong disease surveillance systems, TB elimination initiatives, and increased adoption of innovative diagnostic technologies.

    How does Singapore's latent TB testing market compare to other Asia Pacific countries?

    Singapore's latent TB testing market benefits from superior healthcare infrastructure, robust regulatory frameworks, and strategic positioning as a regional diagnostic hub, supporting higher market penetration than many regional peers.

    What testing technologies are most prevalent in Singapore's latent TB market?

    Singapore's latent TB testing market utilizes interferon-gamma release assays (IGRAs), tuberculin skin tests (TST), and emerging molecular diagnostic platforms, with preference for rapid, accurate methods in clinical and occupational health settings.

    RESEARCH METHODOLOGY

    The study involved major activities in estimating the current market size for the latent TB testing market. Exhaustive secondary research was done to collect information on the latent TB testing industry. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain using primary research. Different approaches, such as top-down and bottom-up, were employed to estimate the total market size. After that, the market breakup and data triangulation procedures were used to estimate the market size of the segments and subsegments of the latent TB testing market.

    The four steps involved in estimating the market size are

    Secondary Research

    In the secondary research process, various secondary sources such as annual reports, press releases & investor presentations of companies, white papers, certified publications, articles by recognized authors, gold-standard & silver-standard websites, regulatory bodies, and databases (such as D&B Hoovers, Bloomberg Business, and Factiva) were referred to identify and collect information for this study.

    Primary Research

    In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. Primary sources were mainly industry experts from the core and related industries and preferred suppliers, manufacturers, distributors, service providers, technology developers, researchers, and organizations related to all segments of this industry’s value chain. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts, C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative and quantitative information as well as assess prospects.

    The following is a breakdown of the primary respondents:

    Note 1: Others include sales managers, marketing managers, and product managers.

    Note 2: Companies are classified into tiers based on their total revenues. As of 2022/2023, Tier 1 = >USD 100 million, Tier 2 = USD 10 million to USD 100 million, and Tier 3 = < USD 10 million.

    To know about the assumptions considered for the study, download the pdf brochure

    COMPANY NAME DESIGNATION
    QIAGEN General Manager
    Revvity Area Sales Manager

    Market Size Estimation

    Both top-down and bottom-up approaches were used to estimate and validate the latent TB testing market's total size. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

    • The key players in the industry have been identified through extensive secondary research
    • The revenues generated by leading players operating in the latent TB testing market have been determined through primary and secondary research.
    • All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources.

    The research methodology used to estimate the market size includes the following:

    Data Triangulation

    After arriving at the overall market size by applying the process mentioned above, the total market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.

    Market Definition

    Latent tuberculosis testing refers to diagnosing the infection by detecting an immune response to Mycobacterium tuberculosis antigens using either the tuberculin skin test (TST) or interferon-gamma release assays (IGRAs). These tests help identify dormant tuberculosis infections in individuals without active symptoms.

    Stakeholders

    • Senior Management
    • End User
    • Finance/Procurement Department  
    • R&D Department

    Report Objectives

    • To define, describe, segment, and forecast the global latent TB testing market, by test type, application, end user, and region
    • To provide detailed information regarding the major factors influencing the market growth (such as drivers, restraints, opportunities, and challenges)
    • To analyze the micromarkets1 with respect to individual growth trends, prospects, and contributions to the overall latent TB testing market
    • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
    • To forecast the size of the market segments with respect to five regions, namely, North America, Europe, the Asia Pacific, Middle East & Africa, and Latin America
    • To profile the key players and comprehensively analyze their product portfolios, market positions, and core competencies
    • To track and analyze company developments such as product launches & approvals, partnerships, acquisitions, agreements, and other developments
    • To benchmark players within the market using the proprietary Competitive Leadership Mapping framework, which analyzes market players on various parameters within the broad categories of business and product excellence

     

    Get the Full Latent TB Testing Market Report

    Full forecast, segment splits, and company analysis for all Latent TB Testing Market.

    Need a Tailored Report?

    Customize this report to your needs

    Get 10% FREE Customization

    Customize This Report
    Fact checked
    DMCA.com Protection Status